期刊文献+

比较密骨胶囊与维生素D_3对糖皮质激素性骨质疏松模型骨量、骨强度影响的研究 被引量:5

Comparison of effect or Migu Capsule and Vit D_3 on bone quantity and bone strength in rats with osteoporosis induced by glucocorticoid
下载PDF
导出
摘要 目的:比较性地研究密骨胶囊与维生素D3对糖皮质激素性骨质疏松模型骨量、骨强度的影响。方法;采用12月龄SD雄性大鼠46只,随机分为空白对照组14只、地塞米松组16只、密骨胶囊组8只、维生素D3组8只。地塞米松的剂量是0.25mg/100g体重/次(每周两次);密骨胶囊浸膏的剂量是0.166g/100g体重/次(每天一次);维生素D3的剂量是0.25U/100g体重/次(第一周每天一次,一周以后每周三次)。各组施行相应处理,18周以后分别测定各组大鼠全身骨密度、股骨抗弯强度。结果:密骨胶囊既能部分地恢复模型大鼠已经丢失的骨量(高于地塞米松组p<0.05,低于空白对照组p<0.05),又能部分地回升模型大鼠已经降低的骨强度(高于地塞米松组p<0.05,低于空白对照组p<0.05);维生素D3也能部分地恢复模型大鼠已经丢失的骨量(高于地塞米松组p<0.05,低于空白对照组p<0.05),亦能部分地回升模型大鼠已经降低的骨强度(高于地塞米松组p<0.05,低于空白对照组p<0.05),但回升能力比较密骨胶囊有下降趋势。结论:密骨胶囊是一种具有开发潜力的抗糖皮质激素性骨质疏松的中药复方. AIM:To compare the effect of Migu Capsule (a compound traditional Chinese medicine)and Vit D3 on bone quantity and bone strength in rats with osteoporosis induced by glucocorticoid.METHODS: Forty-six male Sprague-Dawley rats, 12 months of age,were divided randomizedly into four groups: control group (n=14), dexamethasone group (n=16), Migu Capsule group (n=8) and Vit D3 group(n=8). The dosages of medication were 0. 25mg/100g body weight(twice a week) for dexamethasone, 0.166g/100g body weight (once a day) for Migu Capsule and 0.25U/1009 body weight (once a day in the first week and then three times a week) for Vit D3,all for 18 weeks. General bone mineral density and femur bending strength were measured after the termination of treatment. RESULTS: Migu Capsule could not only partially recover the lost bone quantity (higher than the dexamethasone group, p<0.05,lower than the control group, p<0.05)but also partially elevate the decreased bone strength(higher than the dexamethasone group,p<0.05 , lower than the control group, p<0.05). Vit D3 could also partially recover the lost bone quantity(higher than the dexamethasone group p<0.05,lower than control group p <0.05), and partially elevate the decreased bone strength (higher than the dexamethasone group, p<0.05,lower than the control group p<0.05),but a dropping tendency was observed (compared with the Migu Capsule group). CONCLUSION:Migu Capsule is a useful drug to treat osteoporosis induced by glucocorticoid. Its ability to elevate the decreased bone strength might be attributed to its effect on microstructure of bone tissue,which needs further study.
出处 《中国骨质疏松杂志》 CAS CSCD 1997年第3期9-11,8,共4页 Chinese Journal of Osteoporosis
基金 上海市科委资助
关键词 密骨胶囊 骨量 地塞米松 骨强度 维生素D3 空白对照 糖皮质激素 大鼠 骨质疏松模型 Migu Capsule VitD3 Osteoporosis Glucocorticoid Bone quantity Bone strength
  • 相关文献

参考文献2

二级参考文献1

  • 1李景学,骨与关节X线诊断学,1982年

共引文献6

同被引文献71

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部